Dr. Anita Gupta, WEF Member Expert and World Women Davos Agenda Delegate, is a pioneering physician anesthesiologist-pharmacist renowned for her innovative solutions to critical health challenges. Serving in roles ranging from General Partner, SVP, and Senior Advisor at the Milken Institute to Chief Surgeon of New York City, she leads impactful initiatives addressing the global drug crisis and expanding access to medicine. Appointed by the American Society of Anesthesiologists, Dr. Gupta advocates for expanded naloxone access at the U.S. FDA and provides frontline insights into the drug crisis. Her expertise on synthetic opioids, the drug trade, and early warning systems has been internationally recognized and awarded. Dr. Gupta also contributes to the WEF Global Member Experts on Biotechnology, Pandemic Preparedness, and the Future of Health, as well as the National Academies of Medicine Cancer Policy Forum and the Global Innovation Forum. Her leadership spans top governmental, academic, and industry institutions, including the U.S. FDA, National Quality Forum, Department of Defense, the Gates Foundation’s Innovation Equity Forum, the Board of Governors of the Princeton Asian American Alumni Association, and Harvard's Alumnae for Women. Honored by the New York Times, Washington Post, Forbes, and WebMD's 'Pain Expert Blog,' Dr. Gupta is celebrated as one of the most influential healthcare experts globally. She has earned numerous accolades, including being named a Top Thinker, one of the Top 100 Most Inspiring Leaders, a Top Woman in Business, one of the Top 10 Fierce Healthcare Women of Influence, and a Top 10 Global Emerging Leader. Additionally, she is a recipient of the National Academies Patient Advocacy Award and a Goldman Sachs 10,000 Small Business Scholar. As a leading force in healthcare transformation, Dr. Gupta exemplifies the World Economic Forum’s dedication to equitable healthcare access.